In summary, 19 out of 34 patients (55.9%) who had a TERT promoter mutation in the primary or metastatic lesion associated with a primary melanoma trunk site, developed visceral spreading as the first site of progression (OR 3.64, CI 1.14–11.66). This evidence concerns the gene TERT and melanoma.